Neurometrix Inc news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

NURO 0.960 +0.020 (2.13%)
price chart
Form 8-K NeuroMetrix, Inc. For: Jun 08
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.
NeuroMetrix to Unveil Revolutionary Wearable Pain Relief Device at 2015 ...
NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders.
Related articles »  
Eye Catching Healthcare Sectors- Pfizer Inc. (NYSE:PFE), NeuroMetrix Inc ...
Pfizer Inc. (NYSE:PFE) released that it broke ground for a $95M consumer products production facility in Suzhou, China. The new site is close to the firm's existing Suzhou site and will help surge production capacity to meet growing demand for Pfizer ...
Zacks Rating on NeuroMetrix, Inc.
NeuroMetrix, Inc. (NASDAQ:NURO) remains a strong buy in the latest set of rankings. The counter has received an average rating of 1 by 1 analysts.
Company Shares of NeuroMetrix, Inc. Drops by -8.47%
NeuroMetrix, Inc. (NASDAQ:NURO) has lost 8.47% during the past week and dropped 12.02% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 8.1%.
NeuroMetrix, Inc. Short Interest Update
NeuroMetrix, Inc. (NASDAQ:NURO), A drop of 241,269 shares or 44.6% was seen in the short interest of NeuroMetrix, Inc.. Even as the interest dropped from 540,684 shares on May 29,2015 to 299,415 shares on June 15,2015, the days to cover came in at 1.
NeuroMetrix (NURO) Stock Gains on Launch of Quell, its Wearable Pain Treatment
"We rate NEUROMETRIX INC (NURO) a SELL. This is driven by several weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks ...
NeuroMetrix Launches Quell™ Wearable Pain Relief Technology  MarketWatch
NeuroMetrix (NURO) Announces Full Commercial Launch of Quell  StreetInsider.com
Morning Buzz: NeuroMetrix Inc. (NASDAQ:NURO), Xinyuan Real Estate (NYSE ...
NeuroMetrix Inc. (NASDAQ:NURO) belongs to Healthcare sector. Its weekly performance is -3.06%. On last trading day company shares ended up $1.24.
Sabby Management Buys 3 Biotech Stocks
Traders may want to take note of holdings disclosed by Sabby Management LLC to the SEC on Thursday. The firm reported 9.99 percent ownership stakes in the following biotech companies: Neurometrix Inc (NASDAQ: NURO) is a medical device company ...
NeuroMetrix Announces First Shipments of Quell™ Wearable Pain Relief Device
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) reported that it has started shipping Quell wearable pain relief devices out of its production and fulfillment facility in Woburn, MA.